Gómez-Urquiza, J.L.; Romero-Bejar, J.L.; Chami-Peña, S.; Suleiman-Martos, N.; Cañadas-De la Fuente, G.A.; Molina, E.; Riquelme-Gallego, B.
Efficacy and Safety of New B Cell-Targeted Biologic Agent for the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. J. Clin. Med. 2023, 12, 4848.
https://doi.org/10.3390/jcm12144848
AMA Style
Gómez-Urquiza JL, Romero-Bejar JL, Chami-Peña S, Suleiman-Martos N, Cañadas-De la Fuente GA, Molina E, Riquelme-Gallego B.
Efficacy and Safety of New B Cell-Targeted Biologic Agent for the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2023; 12(14):4848.
https://doi.org/10.3390/jcm12144848
Chicago/Turabian Style
Gómez-Urquiza, José L., José L. Romero-Bejar, Sara Chami-Peña, Nora Suleiman-Martos, Guillermo A. Cañadas-De la Fuente, Esther Molina, and Blanca Riquelme-Gallego.
2023. "Efficacy and Safety of New B Cell-Targeted Biologic Agent for the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 12, no. 14: 4848.
https://doi.org/10.3390/jcm12144848
APA Style
Gómez-Urquiza, J. L., Romero-Bejar, J. L., Chami-Peña, S., Suleiman-Martos, N., Cañadas-De la Fuente, G. A., Molina, E., & Riquelme-Gallego, B.
(2023). Efficacy and Safety of New B Cell-Targeted Biologic Agent for the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 12(14), 4848.
https://doi.org/10.3390/jcm12144848
